Myelodysplastic Syndromes Treatment: Past, present and goals for the future

2 Views
administrator
administrator
07/04/23

Aref Al-Kali, M.D., discusses Myelodysplastic Syndromes (MDS) treatment and the case-based session at the 2019 American Society of Clinical Oncology's (ASCO) conference. The session includes providers from all over the world and focuses on 'How to Use Hypomethylating Agents in Combination Therapy.' Learn more about MDS treatment and research.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next